Indo Us Biotech Limited — Board Meeting, 11-02-2025: Outcome of Board Meeting

The Board has approved the unaudited financial results for the quarter ended December 31, 2024. Revenue from operations stood at ₹235.64 Cr, while total income was ₹235.83 Cr. Total expenses reached ₹185.65 Cr, resulting in a profit before tax of ₹5.02 Cr. The net profit after tax was ₹5.05 Cr. Earnings per share (EPS) for the quarter is ₹2.52. The meeting focused on these results and included a review from the auditors, confirming compliance with accounting standards.